Walmsley S - Search Results

1

Mild to moderate symptoms do not correlate with lactate levels in HIV-positive patients on nucleoside reverse transcriptase inhibitors.

Tan D, Walmsley S, Shen S, Raboud J. Tan D, et al. Among authors: walmsley s. HIV Clin Trials. 2006 May-Jun;7(3):107-15. doi: 10.1310/95VE-A6KJ-WRQ0-1F8Y. HIV Clin Trials. 2006. PMID: 16880167 Clinical Trial.

2

Clinical impact of double protease inhibitor boosting with lopinavir/ritonavir and amprenavir as part of salvage antiretroviral therapy.

Loutfy M, Raboud J, Thompson C, Tseng A, Abdurrahman Z, Kovacs C, Rachlis A, Phillips E, Rubin G, Gough K, Walmsley S. Loutfy M, et al. Among authors: walmsley s. HIV Clin Trials. 2003 Sep-Oct;4(5):301-10. doi: 10.1310/7LYW-GQFF-WPRQ-K3QW. HIV Clin Trials. 2003. PMID: 14583846

3

Rosiglitazone for HIV-1 lipoatrophy.

Cavalcanti RB, Raboud J, Kain KC, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. Lancet. 2004 May 29;363(9423):1828-9; author reply 1829. doi: 10.1016/S0140-6736(04)16318-6. Lancet. 2004. PMID: 15172791 No abstract available.

4

Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research.

Cavalcanti RB, Cheung AM, Raboud J, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. J Clin Densitom. 2005 Fall;8(3):293-7. doi: 10.1385/jcd:8:3:293. J Clin Densitom. 2005. PMID: 16055959

5

Is chromium an important element in HIV-positive patients with metabolic abnormalities? An hypothesis generating pilot study.

Aghdassi E, Salit IE, Fung L, Sreetharan L, Walmsley S, Allard JP. Aghdassi E, et al. Among authors: walmsley s. J Am Coll Nutr. 2006 Feb;25(1):56-63. doi: 10.1080/07315724.2006.10719515. J Am Coll Nutr. 2006. PMID: 16522933

6

Lopinavir plus ritonavir: a novel protease inhibitor combination for HIV infections.

Tan D, Walmsley S. Tan D, et al. Among authors: walmsley s. Expert Rev Anti Infect Ther. 2007 Feb;5(1):13-28. doi: 10.1586/14787210.5.1.13. Expert Rev Anti Infect Ther. 2007. PMID: 17266450 Review.

7

A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy.

Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S. Cavalcanti RB, et al. Among authors: walmsley s. J Infect Dis. 2007 Jun 15;195(12):1754-61. doi: 10.1086/518005. Epub 2007 May 2. J Infect Dis. 2007. PMID: 17492590 Clinical Trial.

8

Systematic review of strategies to measure HIV-related diarrhea.

Tinmouth J, Kandel G, Tomlinson G, Walmsley S, Steinhart HA, Glazier R. Tinmouth J, et al. Among authors: walmsley s. HIV Clin Trials. 2007 May-Jun;8(3):155-63. doi: 10.1310/hct0803-155. HIV Clin Trials. 2007. PMID: 17621462 Review.

9

An estimate of the proportion of symptoms reported in self-administered questionnaires that are captured as adverse drug events in an observational database.

Raboud J, Lesosky M, Sterling S, Phillips E, Walmsley S, Bayoumi A. Raboud J, et al. Among authors: walmsley s. HIV Clin Trials. 2007 Sep-Oct;8(5):311-9. doi: 10.1310/hct0805-311. HIV Clin Trials. 2007. PMID: 17956832 Free article.

10

Evaluation of Stool frequency and stool form as measures of HIV-related diarrhea.

Tinmouth J, Tomlinson G, Kandel G, Walmsley S, Steinhart HA, Glazier R. Tinmouth J, et al. Among authors: walmsley s. HIV Clin Trials. 2007 Nov-Dec;8(6):421-8. doi: 10.1310/hct0806-421. HIV Clin Trials. 2007. PMID: 18042507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

599 results

Search Page